story of the week
Safety and Efficacy of Once-Weekly Basal Insulin Fc in People With Type 2 Diabetes Previously Treated With Basal Insulin
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Diabetes & Endocrinology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Safety and efficacy of once-weekly basal insulin Fc in people with type 2 diabetes previously treated with basal insulin: a multicentre, open-label, randomised, phase 2 study
Lancet Diabetes Endocrinol 2023 Feb 06;[EPub Ahead of Print], J Frias, J Chien, Q Zhang, E Chigutsa, W Landschulz, K Syring, P Wullenweber, A Haupt, C KazdaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.